JPMorgan Healthcare Leaders ETF
$61.73−0.04 (−0.07%)
- Expense ratio
- 0.65%
- Fund size
- $9M
- 1Y return
- +20.8%
- Yield · Last 12 months
- 0.83%
- Holdings
- 58
- Volume · 30D
- 0M sh
- NAV per share
- $61.62
- 52W range
The ETF.net JDOC Grade
Score 41 of 100 sits in the C band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.CScore 49Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.Not scoredRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.CScore 52Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.FScore 4Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.BScore 59Category rankDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.CScore 40Category rank
Our read on JDOC
CMost healthcare ETFs just buy the sector list. JDOC is the stock-picker's version: about 60 names chosen by J.P. Morgan healthcare specialists hunting companies whose future growth the market underrates, with the whole globe in bounds.
Seeks long-term capital appreciation by investing primarily in healthcare companies that the adviser considers leaders, particularly where future growth is underappreciated by the market.
Why people hold it
- Concentrated by design: about 60 healthcare stocks rather than the full sector roster, so the managers' picks actually shape the portfolio.am.jpmorgan.com
- The mandate is global, so European and Asian drugmakers and device firms are as eligible as US-listed ones.am.jpmorgan.com
- Run by J.P. Morgan portfolio managers who specialize in healthcare inside its equity research groups, leaning on the firm's global bench of sector analysts.sec.govam.jpmorgan.com
- 0.65% a year for specialist active research sits right at the median fee for actively managed US equity ETFs, not a markup for the J.P. Morgan name.
Worth knowing
- A small fund that trades thinly since its 2023 launch, so spreads can run wider than on the giant healthcare index ETFs and execution matters more.
- One sector, roughly 60 names. Drug pricing rules, patent cliffs and trial outcomes land harder here than in a diversified fund.prnewswire.com
- Broad active core rivals like DFAC and AVLC charge under 0.2% for far wider portfolios. JDOC's fee reflects a narrow specialist mandate, not a core holding's price.
JDOC Holdings
- Stocks
- 58
- 47%
- ABBV
Sectors
- Health Care100.0%
Geography
- United States73.68%
- United Kingdom6.91%
- Switzerland5.51%
- Denmark4.38%
- Netherlands2.71%
- Japan2.66%
- Israel1.98%
- Germany1.55%
- 0.62%
Developed 92% · Emerging 8%
JDOC Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | JDOC |
|---|---|
| Year to date | +6.8% |
| 1 month | −3.9% |
| 3 months | +8.0% |
| 1 year | +20.8% |
| 3 years | — |
| 5 years | — |
| 10 years | — |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | JDOC |
|---|---|---|
| 2026 YTD | +6.8% | |
| 2025 | +15.4% | |
| 2024 | −1.0% | |
| 2023 | +10.7% |
JDOC in the news
ETF.net Research hasn’t filed on JDOC yet — coverage lands here as it’s written.
JDOC Dividends
- 0.83%
- $0.51
- $0.51 per share
- Annual
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Dec 16, 2025 | Dec 18, 2025 | $0.51 |
| Dec 24, 2024 | Dec 27, 2024 | $0.33 |
| Dec 16, 2024 | Dec 18, 2024 | $2.49 |
| Dec 19, 2023 | Dec 22, 2023 | $0.08 |
JDOC Risk
- 13.8%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 0.46
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −20.8%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.45
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
JDOC Cost
- The middle half of US Active Sector funds
- Median 0.65%
14 of the 33 US Active Sector funds charge less.